S

Surya Pharmaceutical

SURYAPHARM

Tapetide Score

Data-driven rating, 0–100. How it works →

Key Insights

Weaknesses

5
  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of -34.2% over past five years.
  • Company has a low return on equity of -51.2% over last 3 years.
  • Company has high debtors of 1,363 days.
  • Working capital days have increased from 2,034 days to 5,556 days

Growth Rate

Revenue Growth
-178% lower than 3Y
Net Income Growth
126%

Quarterly Results

Particulars Mar 2013Jun 2013Sep 2013Dec 2013Mar 2014Jun 2014Sep 2014Dec 2014
Sales
-15
6
5
1
2
0
0
0
Expenses
110
9
8
618
13
2
2
1
Operating Profit
-125
-3
-3
-617
-11
-1
-1
-1
OPM %
—
-54%
-69%
-102843%
-492%
-251%
-293%
—
Other Income
-18
0
0
-219
0
0
0
0
Interest
38
62
69
16
108
0
0
0
Depreciation
34
16
16
16
16
16
16
16
PBT
-215
-81
-88
-868
-134
-17
-17
-17
Tax %
0%
0%
0%
0%
-331%
0%
0%
0%
Net Profit
-215
-81
-88
-868
310
-17
-17
-17
EPS in Rs
-10.6
-3.97
-4.35
-42.8
15.28
-0.83
-0.84
-0.85
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2006Mar 2007Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013TTM
Sales
239
283
486
723
1,134
1,600
1,623
60
3
Expenses
192
231
400
602
973
1,337
1,765
214
18
Operating Profit
47
52
86
120
161
263
-142
-154
-14
OPM %
20%
18%
18%
17%
14%
16%
-9%
-255%
-476%
Other Income
0
3
5
1
13
3
-38
-35
0
Interest
14
16
26
41
62
108
179
207
108
Depreciation
6
8
9
16
21
27
35
62
63
PBT
27
30
56
64
90
132
-393
-459
-185
Tax %
21%
22%
26%
12%
16%
24%
-31%
-34%
—
Net Profit
21
24
42
56
76
100
-273
-302
259
EPS in Rs
—
16.37
28.83
38.8
52.57
5.2
-13.47
-14.89
12.76
Div. Payout %
0%
0%
3%
3%
3%
3%
0%
0%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2006Mar 2007Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013
Equity Capital
11
14
14
14
14
19
20
20
Reserves
80
124
164
216
289
501
227
-75
Borrowings
148
196
318
501
708
1,441
1,754
2,009
Other Liabilities
54
60
124
218
375
205
126
63
Total Liabilities
293
394
621
949
1,386
2,166
2,128
2,017
Fixed Assets
62
81
162
213
229
404
728
671
CWIP
31
61
30
88
199
232
7
8
Investments
0
0
0
0
6
26
34
16
Other Assets
200
251
429
648
953
1,504
1,358
1,323
Total Assets
293
394
621
949
1,386
2,166
2,128
2,017
Figures in ₹ Crores

Cash Flow

Particulars Mar 2006Mar 2007Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013
Operating
24
-5
68
-8
165
69
386
166
Investing
-48
-56
-54
-121
-144
-245
-150
-8
Financing
61
25
13
103
-11
174
-241
-160
Net Cash Flow
38
-36
26
-25
10
-2
-6
-3
Free Cash Flow
-24
-62
9
-133
18
-165
262
157
CFO/OP
58
0
85
6
108
32
-356
-201
Figures in ₹ Crores

Ratios

Particulars Mar 2006Mar 2007Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013
Debtor Days
77
95
62
69
49
66
53
1,363
Inventory Days
172
235
238
247
271
309
179
1,254
Days Payable
63
63
88
117
108
20
10
56
Cash Conversion Cycle
185
266
212
199
212
355
222
2,561
Working Capital Days
171
251
213
220
184
308
238
5,556
ROCE %
—
16%
20%
18%
17%
16%
-11%
-12%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Surya Pharmaceutical insights

29 extracted metrics + investor summaries across FY06–FY13.

Log in — free

Documents

Frequently Asked Questions about Surya Pharmaceutical

What does Surya Pharmaceutical Ltd do?
Surya Pharmaceuticals Ltd. ventures as a pharmaceutical company. The businesses include Contract Manufacturing, Custom Synthesis, FTE Research, and the manufacture and marketing of pharmaceuticals products and services to clients worldwide. Surya Pharmaceuticals' wide range of product portfolio i...
Which sector does Surya Pharmaceutical Ltd belong to?
Surya Pharmaceutical Ltd is classified under the Healthcare sector, in the Pharmaceuticals & Biotechnology industry.

Company Information

Surya Pharmaceuticals Ltd. ventures as a pharmaceutical company. The businesses include Contract Manufacturing, Custom Synthesis, FTE Research, and the manufacture and marketing of pharmaceuticals products and services to clients worldwide. Surya Pharmaceuticals' wide range of product portfolio includes Active Pharmaceutical Ingredients (APIs), Fine Intermediates, Finished Drug Formulations (FDFs), Phyto Pharmaceuticals and CRAMS.

Website suryapharma.com
Face Value ₹ 1

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/SURYAPHARM.md for Surya Pharmaceutical Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our MCP server.

Explore More

More in Healthcare → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List